Birmingham, West Midlands -- (SBWIRE) -- 01/30/2014 -- Value Penny Stocks issues special report on_ BArray Biopharma Inc (NASDAQ:ARRY), Sanmina Corp (NASDAQ:SANM), Ares Capital Corporation (NASDAQ:ARCC), Vical Incorporated (NASDAQ:VICL).
Array Biopharma Inc (NASDAQ:ARRY) ended its recent business day with the tumbled of -5.74% and closed at the price of $4.93 after opening at $5.15. The stock traded during its last trading session with the total volume of 1.25 million shares, as compared to its average volume of 1.36 million shares. Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific.
Has ARRY Found The Bottom And Ready To Gain Momentum? Find Out Here
Sanmina Corp (NASDAQ:SANM) remained among the day bearish -1.92% and traded with volume of 1.24 million shares in the last session, as compared to average volume of 961,097.00 shares. In comparison with 52 week range of $9.12 - $18.44, it faced lowest price of $16.32 during the last trading session whereas its day highest price was $17.00. The company’s total market capitalization is $1.38 billion, along with 84.15 million shares outstanding. Sanmina Corporation provides integrated electronics manufacturing services worldwide. It offers product design and engineering services, including initial development, detailed design, prototyping.
Why Should Investors Buy SANM After the Recent Fall? Just Go Here and Find Out
Ares Capital Corporation (NASDAQ:ARCC) showed 1.23 million shares in volume during the last trading session, while the average trading volume remained 1.72 million shares. The stock kicked off its trading session at $17.64 and closed at $17.57 after dropped -0.96%.
Will ARCC Get Buyers Even After The Recent Rally? Find Out Here
Vical Incorporated (NASDAQ:VICL) stock traded during its last trading session with the total traded volume of 1.22 million shares versus its average volume of 2.33 million shares. The company opened its trade at the price of $1.37 and its closing price was $1.34 after fell -2.90% for the day. Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Has VICL Found The Bottom and Ready To Move Up? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)